Eltrombopag
TPL104054
Phase 3 small_molecule terminated
Quick answer
Eltrombopag for Non-alcoholic Steatohepatitis is a Phase 3 program (small_molecule) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline
- Indication
- Non-alcoholic Steatohepatitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated